ArticleAnnals of the rheumatic diseases2021

Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study.

Dimitrios A Pappas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.